Home Health FDA warns against combination of malaria drug and Gilead’s remdesivir

FDA warns against combination of malaria drug and Gilead’s remdesivir

0
FDA warns against combination of malaria drug and Gilead’s remdesivir

[ad_1]

(Reuters) – The U.S. Food and Drug Administration on Monday issued a warning to healthcare providers against administering malaria drug hydroxychloroquine or chloroquine in combination with Gilead Sciences’ experimental COVID-19 drug, remdesivir.

The agency said the co-administration may result in reduced antiviral activity of remdesivir. (reut.rs/30I9w1O)

Reporting by Trisha Roy in Bengaluru; Editing by Shinjini Ganguli

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here